Cargando…

Inhibition of LXRα/SREBP-1c-Mediated Hepatic Steatosis by Jiang-Zhi Granule

Nonalcoholic fatty liver (NAFL) is increasingly recognized as one of the most common causes of chronic liver disease worldwide. Traditional Chinese medicine (TCM), as the alternative and complementary medicine, may provide some profound health benefit. “Jiang-Zhi” Granule (JZG) was composed based on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Miao, Sun, Shanshan, Wu, Tao, Zhang, Li, Song, Haiyan, Hao, Weiwei, Zheng, Peiyong, Xing, Lianjun, Ji, Guang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670567/ https://www.ncbi.nlm.nih.gov/pubmed/23762146 http://dx.doi.org/10.1155/2013/584634

Ejemplares similares

Jiang Zhi Granule protects immunological barrier of intestinal mucosa in rats with non-alcoholic steatohepatitis
por: Yu, Xiao, et al.
Publicado: (2021)

Systems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of Jiang Zhi Granule on non-alcoholic fatty liver disease
por: Zheng, Yiyuan, et al.
Publicado: (2018)

Autophagy activation by Jiang Zhi Granule protects against metabolic stress-induced hepatocyte injury
por: Zheng, Yi-Yuan, et al.
Publicado: (2018)

Jiang-Zhi granules decrease sensitivity to low-dose CCl(4) induced liver injury in NAFLD rats through reducing endoplasmic reticulum stress
por: Yang, Lili, et al.
Publicado: (2019)

The Efficacy and Safety of Traditional Chinese Medicine (Jiang Zhi Granule) for Nonalcoholic Fatty Liver: A Multicenter, Randomized, Placebo-Controlled Study
por: Pan, Jielu, et al.
Publicado: (2013)

The Effects of Jiang-Zhi-Ning and Its Main Components on Cholesterol Metabolism
por: Chen, Jianxin, et al.
Publicado: (2012)

Expression and clinical significance of LXRα and SREBP-1c in placentas of preeclampsia
por: Jianhua, Li, et al.
Publicado: (2016)

Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation
por: Zhou, Enchen, et al.
Publicado: (2023)

The Active Ingredients of Jiang-Zhi-Ning: Study of the Nelumbo nucifera Alkaloids and Their Main Bioactive Metabolites
por: Chen, Jianxin, et al.
Publicado: (2012)

The SCAP/SREBP Pathway: A Mediator of Hepatic Steatosis
por: Moon, Young-Ah
Publicado: (2017)

Optimization of the proportions of advantageous components in the hypolipidemic “bioequivalent substance system” of Jiang-Zhi-Ning and its mechanism of action
por: Li, Yumiao, et al.
Publicado: (2023)

Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRα/PCSK9 pathway
por: Zhu, Wenqiang, et al.
Publicado: (2022)

Mechanism of AMPK Suppression of LXR-dependent Srebp-1c Transcription
por: Yap, Fuichi, et al.
Publicado: (2011)

Sex-Related Differences of Lipid Metabolism Induced by Triptolide: The Possible Role of the LXRα/SREBP-1 Signaling Pathway
por: Jiang, Zhenzhou, et al.
Publicado: (2016)

Expression of SREBP-1c Requires SREBP-2-mediated Generation of a Sterol Ligand for LXR in Livers of Mice
por: Rong, Shunxing, et al.
Publicado: (2017)

Yin Zhi Huang, a traditional Chinese herbal formula, ameliorates diet-induced obesity and hepatic steatosis by activating the AMPK/SREBP-1 and the AMPK/ACC/CPT1A pathways
por: Yao, Qunyan, et al.
Publicado: (2020)

Effect of BuShen JiangZhi Recipe on Atherosclerosis in ApoE(−/-) Mice by Regulating the Expression of Anpep via mmu_circRNA_22187
por: Yan, Li, et al.
Publicado: (2021)

GP73 regulates Hepatic Steatosis by enhancing SCAP-SREBPs interaction
por: Yang, Xiaoli, et al.
Publicado: (2017)

Cell-specific discrimination of desmosterol and desmosterol mimetics confers selective regulation of LXR and SREBP in macrophages
por: Muse, Evan D., et al.
Publicado: (2018)

Hainan zhi wu zhi /
Publicado: (1964)

Lipid Regulators during Atherogenesis: Expression of LXR, PPAR, and SREBP mRNA in the Human Aorta
por: Shchelkunova, Tatyana A., et al.
Publicado: (2013)

Ouabagenin is a naturally occurring LXR ligand without causing hepatic steatosis as a side effect
por: Tamura, Satoru, et al.
Publicado: (2018)

Sirtuin 1 Regulates SREBP-1c Expression in a LXR-Dependent Manner in Skeletal Muscle
por: Defour, Aurélia, et al.
Publicado: (2012)

Metabolic Modeling Combined With Machine Learning Integrates Longitudinal Data and Identifies the Origin of LXR-Induced Hepatic Steatosis
por: van Riel, Natal A. W., et al.
Publicado: (2021)

LXRα and LXRβ Nuclear Receptors Evolved in the Common Ancestor of Gnathostomes
por: Fonseca, Elza, et al.
Publicado: (2017)

Hydroxylation site–specific and production-dependent effects of endogenous oxysterols on cholesterol homeostasis: Implications for SREBP-2 and LXR
por: Saito, Hodaka, et al.
Publicado: (2022)

RASAL1 induces to downregulate the SCD1, leading to suppression of cell proliferation in colon cancer via LXRα/SREBP1c pathway
por: Wang, Guangchuan, et al.
Publicado: (2019)

Cholesterol metabolism regulation mediated by SREBP-2, LXRα and miR-33a in rainbow trout (Oncorhynchus mykiss) both in vivo and in vitro
por: Zhu, Tengfei, et al.
Publicado: (2020)

A functional interaction between Hippo‐YAP signalling and SREBPs mediates hepatic steatosis in diabetic mice
por: Shu, Zhiping, et al.
Publicado: (2019)

Prevention of Nonalcoholic Hepatic Steatosis by Shenling Baizhu Powder: Involvement of Adiponectin-Induced Inhibition of Hepatic SREBP-1c
por: Tang, Kairui, et al.
Publicado: (2020)

Establishment of a monoclonal antibody for human LXRα: Detection of LXRα protein expression in human macrophages
por: Watanabe, Yuichiro, et al.
Publicado: (2003)

Tanshinone IIA Downregulates Lipogenic Gene Expression and Attenuates Lipid Accumulation through the Modulation of LXRα/SREBP1 Pathway in HepG2 Cells
por: Gao, Wan-Yun, et al.
Publicado: (2021)

JAZF1 ameliorates age and diet-associated hepatic steatosis through SREBP-1c -dependent mechanism
por: Wei, Qin, et al.
Publicado: (2018)

Identfication of Potent LXRβ-Selective Agonists without LXRα Activation by In Silico Approaches
por: Chen, Meimei, et al.
Publicado: (2018)

Aldehyde dehydrogenase 2 and PARP1 interaction modulates hepatic HDL biogenesis by LXRα-mediated ABCA1 expression
por: Li, Luxiao, et al.
Publicado: (2022)

Foam Cell Specific LXRα Ligand
por: Feldmann, Radmila, et al.
Publicado: (2013)

Gamma-Muricholic Acid Inhibits Nonalcoholic Steatohepatitis: Abolishment of Steatosis-Dependent Peroxidative Impairment by FXR/SHP/LXRα/FASN Signaling
por: Xie, Yang, et al.
Publicado: (2023)

Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway
por: Wang, Ling-Fang, et al.
Publicado: (2017)

NF-κB/HDAC1/SREBP1c pathway mediates the inflammation signal in progression of hepatic steatosis
por: Guo, Yunwei, et al.
Publicado: (2020)

miR-206 controls LXRα expression and promotes LXR-mediated cholesterol efflux in macrophages
por: Vinod, Manjula, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_729qvhq8541ddrbect3m2o73h1